Pfizer’s Deal to Cut Medicaid Drug Costs Exposes Washington’s Broken System

In a move President Donald Trump hailed as historic, Pfizer has agreed to lower prescription drug costs for Medicaid by matching the lowest prices offered in other developed countries. This deal, announced amidst looming government shutdown threats, promises relief for state budgets and Medicaid recipients but also throws Washington’s chronic dysfunction into sharp relief. Is America Getting What It Deserves from Its Drugmakers? Pfizer, a New York-based giant responsible for vital medicines including the COVID-19 vaccine Comirnaty and cancer treatments, agreed to most-favored-nation pricing that will apply to both existing and new drugs. While this sounds promising at face value,...